Title: A Leading Immunology Healthcare Company | Sanofi

URL Source: http://www.sanofi.com/

Markdown Content:
A Leading Immunology Healthcare Company | Sanofi
===============

• Our Company
  
  
  • Our Company
  
  
  • Our Legacy
  
  
  • Our Strategy
  
  
  • Governance
    
    
    • Governance
    
    
    • Board of Directors
    
    
    • Executive Committee
    
    
    • Specialist Committees
    
    
    
    
  
  
  • Social Impact
    
    
    • Social Impact
    
    
    • Access to Healthcare
    
    
    • Innovation for Vulnerable Communities
    
    
    • Environmental Sustainability and Resilience
    
    
    • Diversity, Equity, and Inclusion In and Beyond the Workplace
    
    
    • Code of Conduct and Responsible Business
    
    
    
    
  
  
  
  


• Our Science
  
  
  • Our Science
  
  
  • Our Pipeline
  
  
  • Our R&D Focus
    
    
    • Our R&D Focus
    
    
    • Immunology R&D
    
    
    • Neurology R&D
    
    
    • Oncology R&D
    
    
    • Rare Blood Disorders R&D
    
    
    • Rare Diseases R&D
    
    
    • Vaccines R&D
    
    
    • Artificial Intelligence in R&D
    
    
    
    
  
  
  • Technology Platforms
  
  
  • Clinical Trials & Results
    
    
    • Clinical Trials & Results
    
    
    • Find a Clinical Trial
    
    
    • Clinical Study Results
    
    
    • Investigator Sponsored Studies
    
    
    • Diversity in Clinical Trials
    
    
    
    
  
  
  • Scientific Collaboration
    
    
    • Scientific Collaboration
    
    
    • Scientific Collaboration in North America
    
    
    • Scientific Collaboration in Europe
    
    
    • Scientific Collaboration in China
    
    
    
    
  
  
  • Digital
  
  
  • Manufacturing and Supply
  
  
  
  


• Your Health
  
  
  • Your Health
  
  
  • Vaccines & Infectious Diseases
    
    
    • Vaccines & Infectious Diseases
    
    
    • Influenza
    
    
    • Meningococcal Meningitis
    
    
    • Pertussis
    
    
    • Respiratory Syncytial Virus (RSV)
    
    
    • Production
    
    
    • Why Vaccines Matter
    
    
    
    
  
  
  • Medicines
    
    
    • Medicines
    
    
    • Immunology
    
    
    • Neurology
    
    
    • Oncology
    
    
    • Rare Blood Disorders
    
    
    • Rare Diseases
    
    
    • Cardiovascular Diseases
    
    
    • Diabetes
    
    
    
    
  
  
  • Consumer Healthcare
    
    
    • Consumer Healthcare
    
    
    • Sustainability at Sanofi Consumer Healthcare
    
    
    • Allergy
    
    
    • Cough, Cold & Flu
    
    
    • Digestive Wellness
    
    
    • Pain Care
    
    
    • Physical & Mental Wellness
    
    
    
    
  
  
  • Integrated Patient Engagement
  
  
  • Healthcare Professionals Support
    
    
    • Healthcare Professionals Support
    
    
    • Managed Access Programs (MAPs)
    
    
    • Pre-Registration Import Licenses
    
    
    • Post Trial Access (PTA)
    
    
    
    
  
  
  
  


• 
  

  Partnering

  
  
  
  
  • Partnering
  
  
  • Partnering Focus Areas
    
    
    • Partnering Focus Areas
    
    
    • China
    
    
    • Digital
    
    
    • General Medicines
    
    
    • Immunology
    
    
    • Neuroscience
    
    
    • Oncology
    
    
    • Out-Licensing
    
    
    • Rare Disease
    
    
    • Technology Platforms
    
    
    • Vaccines
    
    
    
    
  
  
  • Meet the Partnering Team
  
  
  • Contact Business Development Team
  
  
  
  


• 
  

  Media

  
  
  
  
  • Media
  
  
  • Stories
  
  
  • Press Releases
  
  
  • Contacts
  
  
  
  


• Investors
  
  
  • Investors
  
  
  • News
  
  
  • Results and Presentations
    
    
    • Results and Presentations
    
    
    • Results
    
    
    • Presentations
    
    
    
    
  
  
  • Conferences
  
  
  • Environment, Social, Governance
  
  
  • Private Shareholders
  
  
  • Shares and ADRs
    
    
    • Shares and ADRs
    
    
    • Sanofi stock chart
    
    
    • Dividend
    
    
    • ADRs
    
    
    • Shares, Structure & Vote
    
    
    • Analyst Coverage
    
    
    • Vara consensus
    
    
    • Share Repurchases
    
    
    
    
  
  
  • Bonds
  
  
  • Contacts
  
  
  
  


• Careers

Global

Arno Laber, Lab technican, Frankfurt, Germany

Arno Laber, Lab technican, Frankfurt, Germany

Achieving R&D Excellence

Shaping the Medicines of Tomorrow

Discover more

Our Latest Stories

Read our latest articles

Your Health

February 28, 2025

The Continuous Push for Equity in the Rare Disease Community

Read the article

Our Science

February 26, 2025

A New Target to Transform IBD Treatment

Read the article

Our Science

February 12, 2025

Driving Excellence in Biopharma: Our Formula for Success with McLaren Racing

Read the article

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

About Us

Who We Are

We are an innovative global healthcare company.

Read more

Our Science

We turn the impossible into possible.

Read more

Your Health

We chase the miracles of science to improve people’s lives.

Read more

Our Commitment

We have reimagined a bold sustainable approach.

Read more

Our Pipeline

5

Therapeutic areas

83

Compounds in clinical development

26

Clinical trials in phase 3

Explore our pipeline

Pursue Progress. Discover Extraordinary.

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Explore Career Opportunities 

Our Latest Press Releases

February 28, 2025

Media Update: AAD: new data advance Sanofi’s scientific leadership across innovative treatments for inflammatory skin diseases

Read the Media Update

February 25, 2025

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

Read the Press Release

February 22, 2025

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

Read the Press Release

February 19, 2025

Press Release: Sanofi and CD&R sign Opella share purchase agreement

Read the Press Release

See all press releases

Follow us

Back to top

• Stories


• Contact


• Legal notice


• Privacy & data protection


• Cookies Policy


• Our publications


• Directory


• Sitemap


• Accessibility: partial compliance


• Code of Conduct

© Sanofi 2004-2025 - All rights reserved